Business-to-Business (B2B) is a central concept for business partners to find the balance in a business talk and draw fairly more of the pot. In deciding the most appropriate form of partnership in their business endeavors, stakeholders have numerous considerations such as legal liability distribution of the partners, split of the risks, ease of doing business and, surely, the need of capitals and fair ownership and management of stakes. These considerations get more complex when it comes to establishing B2B in such new fields as Bioeconomy/Biotechnologies.
Traditionally, entrepreneurs have used general forms of partnerships, where rules of splits, shares, and transfers of risks and capitals are codified and regulated in one way or another. Such examples are franchise contracts, distributorship contracts, chain-style business operations, processing-plant arrangements, and others.
However, introduction of high-tech modes of doing business in a new integral sphere between deep knowledge in biology and economy, at the same time, requires new forms of partnerships and mobilization of big teams to provide certain market solution in a deal.
Taking into account all these considerations, adequate and fair B2B formula in Bioeconomy/Biotechnologies is the one where a network of teams of competent professionals are recruited to work in a due course of time for the benefit of the stakeholders. In this sense, stakeholders and experts shall be legally bound to cooperate and jointly achieve the milestones on the path of an expected success.